Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing

- Acquisition of Azora and concurrent private placement positions the combined company to advance its pipeline through key clinical milestones in ulcerative colitis, including Phase 1 initiation in mid-2027